MedTrace Logo

Treatment of Periodontal Intrabony Defects With A-PRF+ or EMD

NCT04404374 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-03-05

No results posted yet for this study

Summary

The aim of this randomized clinical trial was to clinically evaluate and compare the healing of intrabony defects after treatment with advanced platelet-rich fibrin (A-PRF+) to enamel matrix derivatives (EMD) in periodontitis patients.

Conditions

  • Periodontal Diseases

Interventions

PROCEDURE

A-PRF/EMD

Comparing healing effect of an autologous and a xenogenic product

Sponsors & Collaborators

  • Semmelweis University

    lead OTHER

Principal Investigators

  • Ferenc Dr.Dőri, professor · Semmelweis University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-27
Primary Completion
2020-06-30
Completion
2020-12-31

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04404374 on ClinicalTrials.gov